1071541-70-2Relevant articles and documents
ISOQUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 208-209, (2021/02/12)
The present invention relates to a compound suitable for use as a kinase inhibitor
AURORA KINASE MODULATORS AND METHOD OF USE
-
Page/Page column 54-55, (2008/12/04)
The present invention relates to chemical compounds having a general formula I {INSERT STRUCTURE HERE} wherein A1-8, D,, L1, L2, R1, R6-8 and n are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinases. For example, the compounds are capable of modulating Aurora kinase thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of Aurora kinase.